Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Trisenox moves into multiple myeloma clinical trials

Feb. 1, 2001

New peptoid MMP inhibitors useful for cancer, etc.

Feb. 1, 2001

Femara receives E.U. approval as first-line breast cancer therapy

Feb. 1, 2001

Preparation and antitumor activity of new xanthone compound from Asta Medica

Feb. 1, 2001

MTC-DOX assigned orphan drug status for liver cancer Rx by FDA

Feb. 1, 2001

Nastech begins phase I trial of intranasal interferon alfa

Jan. 31, 2001

Caelyx receives approval in Canada for treatment of advanced ovarian cancer

Jan. 31, 2001

Kosan receives NCI grant to improve epothilone production

Jan. 31, 2001

Merck reports synthesis, use of new peptidomimetic protein prenyltransferase inhibitors

Jan. 30, 2001

Inhibitors of JNK, compositions and methods of use described by Vertex team

Jan. 30, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...